Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Thal

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Organic Letters|May 24, 2003
Concise total synthesis of (+/-)-maritidineClaire Bru, Claude Thal, Catherine Guillou
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 29, 2003
Combined treatment with galanthaminium bromide, a new cholinesterase inhibitor, and RS 67333, a partial agonist of 5-HT4 receptors, enhances place and object recognition in young adult and old ratsLaëtitia Lamirault, Catherine Guillou, Claude Thal, et al.
Neurobiology of Learning and Memory|August 23, 2003
(-)-9-Dehydrogalanthaminium bromide, a new cholinesterase inhibitor, enhances place and object recognition memory in young and old ratsLaëtitia Lamirault, Catherine Guillou, Claude Thal, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Synthesis and structure-activity relationships of open D-Ring galanthamine analoguesDenyse Herlem, Marie Thérèse Martin, Claude Thal, et al.
Journal of the American Chemical Society|November 26, 2004
The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug designHarry M Greenblatt, Catherine Guillou, Daniel Guénard, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Organic Letters|May 24, 2003
Concise total synthesis of (+/-)-maritidineClaire Bru, Claude Thal, Catherine Guillou
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 29, 2003
Combined treatment with galanthaminium bromide, a new cholinesterase inhibitor, and RS 67333, a partial agonist of 5-HT4 receptors, enhances place and object recognition in young adult and old ratsLaëtitia Lamirault, Catherine Guillou, Claude Thal, et al.
Neurobiology of Learning and Memory|August 23, 2003
(-)-9-Dehydrogalanthaminium bromide, a new cholinesterase inhibitor, enhances place and object recognition memory in young and old ratsLaëtitia Lamirault, Catherine Guillou, Claude Thal, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Synthesis and structure-activity relationships of open D-Ring galanthamine analoguesDenyse Herlem, Marie Thérèse Martin, Claude Thal, et al.
Journal of the American Chemical Society|November 26, 2004
The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug designHarry M Greenblatt, Catherine Guillou, Daniel Guénard, et al.
Pageof 1